Shandong Sinoglory Health (603182) — Capital Reinvestment Ratio
Shandong Sinoglory Health (603182) has a Capital Reinvestment Ratio of 1.27x as of December 2024, meaning it reinvests 1% of its operating cash flow (CN¥313.81 Million) in capital expenditures (CN¥399.54 Million). See net asset quality index of Shandong Sinoglory Health to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Shandong Sinoglory Health Capital Reinvestment Ratio (2020–2024)
This chart tracks Shandong Sinoglory Health's Capital Reinvestment Ratio across 5 annual periods. Check Shandong Sinoglory Health (603182) total reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Shandong Sinoglory Health (2020–2024)
Year-by-year Capital Reinvestment Ratio for Shandong Sinoglory Health from 2020 to 2024. For live market cap and broader valuation context, see Shandong Sinoglory Health (603182) total market value.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.27x | CN¥313.81 Million | CN¥399.54 Million | ▼ -69.3% |
| 2023 | 4.15x | CN¥37.34 Million | CN¥154.79 Million | ▲ +899.3% |
| 2022 | 0.41x | CN¥109.17 Million | CN¥45.29 Million | ▼ -46.6% |
| 2021 | 0.78x | CN¥43.34 Million | CN¥33.70 Million | ▲ +20.0% |
| 2020 | 0.65x | CN¥109.73 Million | CN¥71.10 Million | — |